Neurotransmitter and Neuromodulator Genes Associated With a History of Depressive Symptoms in Individuals With Alcohol Dependence

Alcoholism: Clinical and Experimental Research

Volumn 35, Issue 3, 2011, Pages 496-505

  Kertes, Darlene A ^a   Kalsi, Gursharan ^b   Prescott, Carol A ^c   Kuo, Po Hsiu ^d   Patterson, Diana G ^e   Walsh, Dermot ^f   Kendler, Kenneth S ^b   Riley, Brien P ^b  

^a UNIVERSITY OF FLORIDA   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

^f HEALTH RESEARCH BOARD   (Ireland)

Author keywords

Alcohol Dependence; Genetic Association; Major Depression

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR BETA1; ALCOHOL; CORTICOTROPIN RELEASING HORMONE BINDING PROTEIN; DOPAMINE; GLUTAMIC ACID; MU OPIATE RECEPTOR; NEUROTRANSMITTER; OPIATE; SEROTONIN; UNCLASSIFIED DRUG;

ADULT; ALCOHOLISM; ARTICLE; BEHAVIOR CONTROL; COMORBIDITY; CRHBP GENE; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; GABRB1 GENE; GENE; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; MARKER GENE; NEUROTRANSMISSION; OPRM1 GENE; PRIORITY JOURNAL; SCORING SYSTEM; SIGNAL TRANSDUCTION; STRESS;

ADULT; ALCOHOLISM; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NEUROTRANSMITTER AGENTS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 79951875115     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2010.01366.x     Document Type: Article

References (62)

1. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders. 4th ed. American Psychiatric Press, Washington, DC.
2. Arias A, Feinn R, Kranzler HR (2006) Association of an Asn40Asp (A118G) polymorphism in the mu-opioid receptor gene with substance dependence: a meta-analysis. Drug Alcohol Depend 83:262-268.
3. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265.
4. Bart G, Kreek MJ, Ott J, LaForge KS, Proudnikov D, Pollak L, Heilig M (2005) Increased attributable risk related to a functional mu-opioid receptor gene polymorphism in association with alcohol dependence in central Sweden. Neuropsychopharmacology 30:417-422.
5. Behan DP, De Souza EB, Lowry PJ, Potter E, Sawchenko P, Vale WW (1995) Corticotropin releasing factor (CRF) binding protein: a novel regulator of CRF and related peptides. Front Neuroendocrinol 16:362-382.
6. Belmaker RH, Agam G (2008) Major depressive disorder. N Engl J Med 358:55-68.
7. Broom DC, Jutkiewicz EM, Rice KC, Traynor JR, Woods JH (2002) Behavioral effects of delta-opioid receptor agonists: potential antidepressants? Jpn J Pharmacol 90:1-6.
8. Bucholz KK, Cadoret R, Cloninger CR, Dinwiddie SH, Hesselbrock VM, Nurnberger JI Jr, Reich T, Schmidt I, Schuckit MA (1994) A new, semi-structured psychiatric interview for use in genetic linkage studies: a report on the reliability of the SSAGA. J Stud Alcohol 55:149-158.
9. Chong RY, Oswald L, Yang X, Uhart M, Lin PI, Wand GS (2006) The mu-opioid receptor polymorphism A118G predicts cortisol responses to naloxone and stress. Neuropsychopharmacology 31:204-211.
10. Coon H, Hicks AA, Bailey ME, Hoff M, Holik J, Harvey RJ, Johnson KJ, Darlison MG, Reimherr F, Wender P, Byerley W (1994) Analysis of GABAA receptor subunit genes in multiplex pedigrees with manic depression. Psychiatr Genet 4:185-191.
11. Crowe RR, Wang Z, Noyes R Jr, Albrecht BE, Darlison MG, Bailey ME, Johnson KJ, Zoëga T (1997) Candidate gene study of eight GABAA receptor subunits in panic disorder. Am J Psychiatry 154:1096-1100.
12. DeRijk R, de Kloet ER (2005) Corticosteroid receptor genetic polymorphisms and stress responsivity. Endocrine 28:263-270.
13. Drolet G, Dumont EC, Gosselin I, Kinkead R, Laforest S, Trottier JF (2001) Role of endogenous opioid system in the regulation of the stress response. Prog Neuropsychopharmacol Biol Psychiatry 25:729-741.
14. Edenberg HJ (2007) The genetics of alcohol metabolism: role of alcohol dehydrogenase and aldehyde dehydrogenase variants. Alcohol Res Health 30:5-13.
15. Edenberg HJ, Dick DM, Xuei X, Tian H, Almasy L, Bauer LO, Crowe RR, Goate A, Hesselbrock V, Jones K, Kwon J, Li TK, Numberger JI Jr, O'Connor SJ, Reich T, Rice J, Schuckit MA, Porjesz B, Foroud T, Begleiter H (2004) Variations in GABRA2, encoding the alpha 2 subunit of the GABA(A) receptor, are associated with alcohol dependence and with brain oscillations. Am J Hum Genet 74:705-714.
16. Edenberg HJ, Foroud T (2006) The genetics of alcoholism: identifying specific genes through family studies. Addict Biol 11:386-396.
17. Enoch MA, Shen PH, Ducci F, Yuan Q, Liu J, White KV, Albaugh B, Hodgkinson CA, Goldman D (2008) Common genetic origins for EEG, alcoholism and anxiety: the role of CRH-BP. PLoS ONE 3:e3620. DOI.
18. Enoch MA, Shen PH, Xu K, Hodgkinson C, Goldman D (2006) Using ancestry-informative markers to define populations and detect population stratification. J Psychopharmacol 20(4 Suppl):19-26.
19. Fergusson DM, Boden JM, Horwood LJ (2009) Tests of causal links between alcohol abuse or dependence and major depression. Arch Gen Psychiatry 66:260-266.
20. Garriock HA, Tanowitz M, Kraft JB, Dang VC, Peters EJ, Jenkins GD, Reinalda MS, McGrath PJ, von Zastrow M, Slager SL, Hamilton SP (2010) Association of mu-opioid receptor variants and response to Citalopram treatment in major depressive disorder. Am J Psychiatry 167:565-573.
21. Goldman D, Oroszi G, Ducci F (2005) The genetics of addictions: uncovering the genes. Nat Rev Genet 6:521-532.
22. Grant BF, Hasin DS, Harford TC (1989) Screening for major depression among alcoholics: an application of receiver operating characteristic analysis. Drug Alcohol Depend 23:123-131.
23. Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC, Compton W, Pickering RP, Kaplan K (2004) Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 61:807-816.
24. Greenfield SF, Weiss RD, Muenz LR, Vagge LM, Kelly JF, Bello LR, Michael J (1998) The effect of depression on return to drinking: a prospective study. Arch Gen Psychiatry 55:259-265.
25. Hasin DS, Grant BF (2002) Major depression in 6050 former drinkers: association with past alcohol dependence. Arch Gen Psychiatry 59:749-800.
26. Herman JP, Ostrander MM, Mueller NK, Figueiredo H (2005) Limbic system mechanisms of stress regulation: hypothalamo-pituitary-adrenocortical axis. Prog Neuropsychopharmacol Biol Psychiatry 29:1201-1213.
27. Hishimoto A, Cui H, Mouri K, Nushida H, Ueno Y, Maeda K, Shirakawa O (2008) A functional polymorphism of the micro-opioid receptor gene is associated with completed suicides. J Neural Transm 115:531-536.
28. Hodgkinson CA, Yuan Q, Xu K, Shen PH, Heinz E, Lobos EA, Binder EB, Cubells J, Ehlers CL, Gelernter J, Mann J, Riley B, Roy A, Tabakoff B, Todd RD, Zhou Z, Goldman D (2008) Addictions biology: haplotype-based analysis for 130 candidate genes on a single array. Alcohol Alcohol 43:505-515.
29. Jutkiewicz EM, Torregrossa MM, Sobczyk-Kojiro K, Mosberg HI, Folk JE, Rice KC, Watson SJ, Woods JH (2006) Behavioral and neurobiological effects of the enkephalinase inhibitor RB101 relative to its antidepressant effects. Eur J Pharmacol 531:151-159.
30. Kendler KS, Gardner CO Jr (1998) Boundaries of major depression: an evaluation of DSM-IV criteria. Am J Psychiatry, 155:172-177.
31. Kennedy SE, Koeppe RA, Young EA, Zubieta JK (2006) Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women. Arch Gen Psychiatry 63:1199-1208.
32. Koob GF, Le Moal M (2008) Review. Neurobiological mechanisms for opponent motivational processes in addiction. Philos Trans R Soc Lond B Biol Sci 363:3113-3123.
33. Kreek MJ (1996) Opioid receptors: some perspectives from early studies of their role in normal physiology, stress responsivity, and in specific addictive diseases. Neurochem Res 21:1469-1488.
34. Lander E, Kruglyak L (1995) Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 11:241-247.
35. Lekman M, Laje G, Charney D, Rush AJ, Wilson AF, Sorant AJ, Lipsky R, Wisniewski SR, Manji H, McMahon FJ, Paddock S (2008) The FKBP5-gene in depression and treatment response - an association study in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Cohort. Biol Psychiatry 63:1103-1110.
36. Lovallo WR (2006) Cortisol secretion patterns in addiction and addiction risk. Int J Psychophysiol 59:195-202.
37. Lynskey MT (1998) The comorbidity of alcohol dependence and affective disorders: treatment implications. Drug Alcohol Depend 52:201-209.
38. McGue M (1999) The behavioral genetics of alcoholism. Curr Dir Psychol Sci 8:109-115.
39. Michels G, Moss SJ (2007) GABAA receptors: properties and trafficking. Crit Rev Biochem Mol Biol 42:3-14.
40. Miranda R, Ray L, Justus A, Meyerson LA, Knopik VS, McGeary J, Monti PM (2010) Initial evidence of an association between OPRM1 and adolescent alcohol misuse. Alcohol Clin Exp Res 34:112-122.
41. Morrow AL, Porcu P, Boyd KN, Grant KA (2006) Hypothalamic-pituitary-adrenal axis modulation of GABAergic neuroactive steroids influences ethanol sensitivity and drinking behavior. Dialogues Clin Neurosci 8:463-477.
42. Nurnberger JI Jr, Foroud T, Flury L, Su J, Meyer ET, Hu K, Crowe R, Edenberg H, Goate A, Bierut L, Reich T, Schuckit M, Reich W (2001) Evidence for a locus on chromosome 1 that influences vulnerability to alcoholism and affective disorder. Am J Psychiatry 158:718-724.
43. Oswald LM, Wand GS (2004) Opioids and alcoholism. Physiol Behav 81:339-358.
44. Pacher P, Kecskemeti V (2004) Trends in the development of new antidepressants. Is there a light at the end of the tunnel? Curr Med Chem 11:925-943.
45. Parsian A, Zhang ZH (1999) Human chromosomes 11p15 and 4p12 and alcohol dependence: possible association with the GABRB1 gene. Am J Med Genet 88:533-538.
46. Prescott CA, Sullivan PF, Kuo PH, Webb BT, Vittum J, Patterson DG, Thiselton DL, Myers JM, Devitt M, Halberstadt LJ, Robinson VP, Neale MC, van den Oord EJ, Walsh D, Riley BP, Kendler KS (2006) Genomewide linkage study in the Irish affected sib pair study of alcohol dependence: evidence for a susceptibility region for symptoms of alcohol dependence on chromosome 4. Mol Psychiatry 11:603-611.
47. Pritchard JK, Stephens M, Donnelly P (2000) Inference of population structure using multilocus genotype data. Genetics 155:945-959.
48. Ray LA, Hutchison KE (2004) A polymorphism of the mu-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans. Alcohol Clin Exp Res 28:1789-1795.
49. Reck BH, Mukhopadhyay N, Tsai HJ, Weeks DE (2005) Analysis of alcohol dependence phenotype in the COGA families using covariates to detect linkage. BMC Genet 6(Suppl 1):S143.
50. Schuckit MA, Gold E, Risch C (1987) Plasma cortisol levels following ethanol in sons of alcoholics and controls. Arch Gen Psychiatry 44:942-945.
51. Shabalina SA, Zaykin DV, Gris P, Ogurtsov AY, Gauthier J, Shibata K, Tchivileva IE, Belfer I, Mishra B, Kiselycznyk C, Wallace MR, Staud R, Spiridonov NA, Max MB, Goldman D, Fillingim RB, Maixner W, Diatchenko L (2009) Expansion of the human mu-opioid receptor gene architecture: novel functional variants. Hum Mol Genet 18:1037-1051.
52. Sheline YI, Wang PW, Gado MH, Csernansky JG, Vannier MW (1996) Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci USA 93:3908-3913.
53. Song J, Koller DL, Foroud T, Carr K, Zhao J, Rice J, Numberger JI Jr, Begleiter H, Porjesz B, Smith TL, Schuckit MA, Edenberg HJ (2003) Association of GABA(A) receptors and alcohol dependence and the effects of genetic imprinting. Am J Med Genet B Neuropsychiatr Genet 117B:39-45.
54. Spitzer RL, Williams JBW (1985) Structured Clinical Interview for DSM-III-R (SCID). New York Psychiatric Institute, Biometrics Research Institute, New York.
55. Uusi-Oukari M, Heikkilä J, Sinkkonen ST, Mäkelä R, Hauer B, Homanics GE, Sieghart W, Wisden W, Korpi ER (2000) Long-range interactions in neuronal gene expression: evidence from gene targeting in the GABA(A) receptor beta2-alpha6-alpha1-gamma2 subunit gene cluster. Mol Cell Neurosci 16:34-41.
56. Valdez GR, Koob GF (2004) Allostasis and dysregulation of corticotropin-releasing factor and neuropeptide Y systems: implications for the development of alcoholism. Pharmacol Biochem Behav 79:671-689.
57. Van de Velde S, Bracke P, Levecque K (2010) Gender differences in depression in 23 European countries. Cross-national variation in the gender gap in depression. Soc Sci Med 71:305-313.
58. Van Den Eede F, Van Broeckhoven C, Claes SJ (2005) Corticotropin-releasing factor-binding protein, stress and major depression. Ageing Res Rev 4:213-239.
59. Vengeliene V, Bilbao A, Molander A, Spanagel R (2008) Neuropharmacology of alcohol addiction. Br J Pharmacol 154:299-315.
60. Wand GS, McCaul M, Yang X, Reynolds J, Gotjen D, Lee S, Ali A (2002) The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade. Neuropsychopharmacology 26:106-114.
61. Winoker G, Cadoret R, Dorzab J, Baker M (1971) Depressive disease: a genetic study. Arch Gen Psychiatry 24:135-144.
62. Zimmerman U, Spring K, Kunz-Ebrecht SR, Uhr M, Wittchen HU, Holsboer F (2004) Effect of ethanol on hypothalamic-pituitary-adrenal system response to psychosocial stress in sons of alcohol-dependent fathers. Neuropsychopharmacology 29:1156-1165.